302 related articles for article (PubMed ID: 22310466)
1. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
Shiba-Ishii A; Noguchi M
Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
[TBL] [Abstract][Full Text] [Related]
2. Stratifin accelerates progression of lung adenocarcinoma at an early stage.
Shiba-Ishii A; Kim Y; Shiozawa T; Iyama S; Satomi K; Kano J; Sakashita S; Morishita Y; Noguchi M
Mol Cancer; 2015 Jul; 14():142. PubMed ID: 26223682
[TBL] [Abstract][Full Text] [Related]
3. High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma.
Shiba-Ishii A; Kano J; Morishita Y; Sato Y; Minami Y; Noguchi M
Int J Cancer; 2011 Nov; 129(10):2445-53. PubMed ID: 21207417
[TBL] [Abstract][Full Text] [Related]
4. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
5. Stratifin Inhibits SCF
Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
[TBL] [Abstract][Full Text] [Related]
6. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
7. Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance.
Shiba-Ishii A
Pathol Int; 2021 Oct; 71(10):655-665. PubMed ID: 34324245
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
[TBL] [Abstract][Full Text] [Related]
9. Frequent aberrant methylation of the promoter region of sterile alpha motif domain 14 in pulmonary adenocarcinoma.
Sun W; Iijima T; Kano J; Kobayashi H; Li D; Morishita Y; Okubo C; Anami Y; Noguchi M
Cancer Sci; 2008 Nov; 99(11):2177-84. PubMed ID: 18823374
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
[TBL] [Abstract][Full Text] [Related]
11. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis.
Luo J; Feng J; Lu J; Wang Y; Tang X; Xie F; Li W
Med Oncol; 2010 Sep; 27(3):791-7. PubMed ID: 19685192
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
14. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
[TBL] [Abstract][Full Text] [Related]
15. Aberrant OCIAD2 demethylation in lung adenocarcinoma is associated with outcome.
Maki M; JeongMin H; Nakagawa T; Kawai H; Sakamoto N; Sato Y; Noguchi M
Pathol Int; 2022 Oct; 72(10):496-505. PubMed ID: 35920378
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylation of the 14-3-3σ promoter leads to increased expression in non-small cell lung cancer.
Radhakrishnan VM; Jensen TJ; Cui H; Futscher BW; Martinez JD
Genes Chromosomes Cancer; 2011 Oct; 50(10):830-6. PubMed ID: 21755566
[TBL] [Abstract][Full Text] [Related]
17. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
19. Association of 5'-CpG island hypermethylation of the FHIT gene with lung cancer in southern-central Chinese population.
Li W; Deng J; Jiang P; Tang J
Cancer Biol Ther; 2010 Nov; 10(10):997-1000. PubMed ID: 20814237
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients.
Mirza S; Sharma G; Parshad R; Srivastava A; Gupta SD; Ralhan R
Clin Biochem; 2010 Mar; 43(4-5):380-6. PubMed ID: 19961842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
